We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2nyy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 2nyy |SIZE=350|CAPTION= <scene name='initialview01'>2nyy</scene>, resolution 2.61&Aring;
|PDB= 2nyy |SIZE=350|CAPTION= <scene name='initialview01'>2nyy</scene>, resolution 2.61&Aring;
|SITE=
|SITE=
-
|LIGAND= <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> and <scene name='pdbligand=CA:CALCIUM ION'>CA</scene>
+
|LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>
|ACTIVITY=
|ACTIVITY=
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=[[2nz9|2NZ9]]
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2nyy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2nyy OCA], [http://www.ebi.ac.uk/pdbsum/2nyy PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2nyy RCSB]</span>
}}
}}
Line 24: Line 27:
[[Category: Arndt, J W.]]
[[Category: Arndt, J W.]]
[[Category: Stevens, R C.]]
[[Category: Stevens, R C.]]
-
[[Category: CA]]
 
-
[[Category: ZN]]
 
[[Category: botulinum]]
[[Category: botulinum]]
[[Category: fab]]
[[Category: fab]]
Line 31: Line 32:
[[Category: protein antibody complex]]
[[Category: protein antibody complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 17:53:04 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:10:24 2008''

Revision as of 01:10, 31 March 2008


PDB ID 2nyy

Drag the structure with the mouse to rotate
, resolution 2.61Å
Ligands: ,
Related: 2NZ9


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1


Overview

Broadening antibody specificity without compromising affinity should facilitate detection and neutralization of toxin and viral subtypes. We used yeast display and a co-selection strategy to increase cross-reactivity of a single chain (sc) Fv antibody to botulinum neurotoxin type A (BoNT/A). Starting with a scFv that binds the BoNT/A1 subtype with high affinity (136 pM) and the BoNT/A2 subtype with low affinity (109 nM), we increased its affinity for BoNT/A2 1,250-fold, to 87 pM, while maintaining high-affinity binding to BoNT/A1 (115 pM). To find the molecular basis for improved cross-reactivity, we determined the X-ray co-crystal structures of wild-type and cross-reactive antibodies complexed to BoNT/A1 at resolutions up to 2.6 A, and measured the thermodynamic contribution of BoNT/A1 and A2 amino acids to wild-type and cross-reactive antibody binding. The results show how an antibody can be engineered to bind two different antigens despite structural differences in the antigen-antibody interface and may provide a general strategy for tuning antibody specificity and cross-reactivity.

About this Structure

2NYY is a Single protein structure of sequence from Clostridium botulinum. Full crystallographic information is available from OCA.

Reference

Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin., Garcia-Rodriguez C, Levy R, Arndt JW, Forsyth CM, Razai A, Lou J, Geren I, Stevens RC, Marks JD, Nat Biotechnol. 2007 Jan;25(1):107-16. Epub 2006 Dec 17. PMID:17173035

Page seeded by OCA on Mon Mar 31 04:10:24 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools